Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Amortization - GoodwillCost of RevenueEBIATGross ProfitReceivables - NetRent ExpenseWages, Salaries and Other
Ratios

Avricore Health (AVCRF) Gross Profit (2016 - 2025)

Avricore Health has reported Gross Profit over the past 11 years, most recently at -$5239.7 for Q4 2025.

  • Quarterly Gross Profit fell 101.24% to -$5239.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $163168.6 through Dec 2025, down 88.11% year-over-year, with the annual reading at $170552.8 for FY2025, 87.58% down from the prior year.
  • Gross Profit was -$5239.7 for Q4 2025 at Avricore Health, up from -$38221.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $422300.9 in Q4 2024 and troughed at -$38221.0 in Q3 2025.
  • The 5-year median for Gross Profit is $140114.3 (2023), against an average of $139567.3.
  • Year-over-year, Gross Profit tumbled 122.92% in 2021 and then skyrocketed 5594.34% in 2022.
  • A 5-year view of Gross Profit shows it stood at $7391.5 in 2021, then surged by 1582.86% to $124388.6 in 2022, then skyrocketed by 196.12% to $368344.6 in 2023, then increased by 14.65% to $422300.9 in 2024, then crashed by 101.24% to -$5239.7 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Gross Profit are -$5239.7 (Q4 2025), -$38221.0 (Q3 2025), and -$34710.8 (Q2 2025).